23 Jan TrakCel
Matthew Lakelin, Ph.D., VP Scientific Affairs & Product Development, Co-Founder
April 9 | 9:30am | Salone dei Cavalieri, Section 2
Cardiff, United Kingdom
(Private)
TrakCel is the first provider of integrated cellular orchestration solutions for the precise management, control and tracking of cell and gene therapy products. With the largest number of live deployments supporting the broadest number of therapy classes in industry, TrakCel has built a deep understanding of the unique challenges faced by advanced therapy developers globally. OCELLOS by TrakCel is a powerful, integrated cellular orchestration solution for the precise management, control and tracking of advanced therapy supply chains, patient by patient. OCELLOS supports autologous, allogeneic and personalised cancer vaccine therapies at all clinical and commercial stages whilst OCELLOS Lite has been developed for quick, cost-effective deployment for early-stage clinical therapies. Our brand-new product OCELLOS Core is an out-of-the-box Chain of Identity and Chain of Custody solution for therapy developers from first in human clinical trials. TrakCel’s cell orchestration platforms help to establish and safeguard the therapy Chain of Identity and Chain of Custody whilst generating full, reportable, electronic audit trails in real-time for each patient. Dashboards and reports unite therapy developers with healthcare providers and supply chain partners, sharing the information needed to guide decisions and creating alerts and notifications to progress the journey. TrakCel SaaS cellular orchestration solutions are built on the Salesforce platform and offer visibility, insight and scalability, streamlining the delivery of more therapies, to more patients at their most vulnerable.
